The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons.

Journal: Open forum infectious diseases
Published Date: Sep 8, 2017

Abstract

BACKGROUND: Persons with HIV and tuberculosis (TB) co-infection require transaminase monitoring while on hepatotoxic medications. A novel paper-based, point-of-care transaminase test is in development at an anticipated cost of $1 per test.

Authors

  • Radha Rajasingham
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Nira R Pollock
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Benjamin P Linas
    Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals